FNDC3B and acute myeloid leukemia: Conversely, FNDC3B, NR5A, and SIMC1 were among the genes identified as AML-specific targets (Fig. 5e, Supplementary Fig. 5a, Supplementary Data 4), and were dramatically upregulated in the AML sample (Fig. 5f).